Liposomes have excellent biocompatibility and rarely cause adverse reactions. Its amphiphilic structure can encapsulate water-soluble and hydrophobic active pharmaceutical ingredients (API), making it an ideal drug delivery tool. A similar product, lipid nanoparticles, has attracted much attention for its ability to effectively deliver therapeutic payloads, including vaccine components such as DNA and mRNA. It delivers payload with high precision and achieves highly specific binding.
This is a new dosage form of γ-aminobutyric acid (GABA). It will have a unique sustained-release design based on the absorption path of GABA in the human body. It will show effects in two forms: 4-hour sustained-release and 8-hour sustained-release. Please Follow Joyous’ detailed introduction
Wir verwenden Cookie, um Ihr Online-Erlebnis zu verbessern. Wenn Sie auf dieser Website weitersurfen, gehen wir davon aus, dass Sie der Verwendung von Cookie zustimmen.
